Johan M. Kros

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 02, 2026

Heterogeneity of MGMT expression in corticotroph adenomas and mechanism of acquired temozolomide resistance.

Heterogeneity of MGMT expression in corticotroph adenomas and mechanism of acquired temozolomide resistance.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 23, 2025

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: July 13, 2025

A unified 3D reconstruction of microscopy and MRI in a brain showing Alzheimer's disease-related neuropathology.

A unified 3D reconstruction of microscopy and MRI in a brain showing Alzheimer's disease-related neuropathology.

Journal: Brain pathology (Zurich, Switzerland)

Published: March 26, 2025

Overexpression of CTLA-4 and fibronectin, and lower expression of CD137 (4-1BB) is associated with brain metastasis of primary skin melanomas. An analysis of local immune response by digital spatial profiling.

Overexpression of CTLA-4 and fibronectin, and lower expression of CD137 (4-1BB) is associated with brain metastasis of primary skin melanomas. An analysis of local immune response by digital spatial profiling.

Journal: Frontiers in immunology

Published: February 18, 2025

T cell induced expression of Coronin-1A facilitates blood-brain barrier transmigration of breast cancer cells.

T cell induced expression of Coronin-1A facilitates blood-brain barrier transmigration of breast cancer cells.

Journal: Scientific reports

Published: June 27, 2024

Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.

Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.

Journal: Acta neuropathologica

Published: June 06, 2024

Biallelic and monoallelic variants in EFEMP1 can cause a severe and distinct subtype of heritable connective tissue disorder.

Biallelic and monoallelic variants in EFEMP1 can cause a severe and distinct subtype of heritable connective tissue disorder.

Journal: European journal of human genetics : EJHG

Published: May 30, 2024

Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.

Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.

Journal: bioRxiv : the preprint server for biology

Published: April 02, 2024

Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study.

Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 21, 2024

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling.

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling.

Journal: Nature cancer

Published: February 28, 2024

Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.

Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.

Journal: Neuro-oncology advances

Published: November 29, 2023

Showing 1-12 of 158

Last Updated: 09/26/2026